Business Standard

Kwality Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Announcement under Regulation 30 (LODR)-Newspaper Publication NEWSPAPER ADVTS OF FINANCIAL RESULTS ATTACHED HEREWITH27/05/2024
Investor Presentation Of The Results Of The Company For The Financial Year Ended 31St March 2024 Investor Presentation of FY 24 RESULTS ATTACHED27/05/2024
Investor Presentation Of The Results Of The Company For The Financial Year Ended 31St March 2024 INVESTOR PRESENTATION OF FY24 RESULTS ATTACHED HEREWITH27/05/2024
Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended 31St March 2024 We wish to inform you that at the Board Meeting held today i.e. on Thursday May ...Read More23/05/2024
FINANCIAL RESULTS FOR THE QTR AND YEAR ENDED 31ST MARCH 2024 AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31-03-2024 ALONGWITH OT...Read More23/05/2024
Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The 4Th Quarter And Financial Year Ended On 31St March 2024 Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Dir...Read More08/05/2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) For The Year Ended On 31St March 2024 Certificate under regulation 40(9) is attached30/04/2024
KWALITY PHARMA RECEIVED INVIMA APPROVAL FOR ITS ONCOLOGY (UNIT-III) VIAL LINE AND TABLET LINE KWALITY PHARMACEUTICAL MANUFACTURING FACILITY ONCOLOGY(UNIT III) AT HIMCHAL PRAD...Read More29/04/2024
KWALITY PHARMA RECEIVED INVIMA APPROVAL FOR ITS AMPOULE AND VIAL PRODUCT LINES KWALITY PHARMA RECEIVED INVIMA APPROVAL FOR ITS AMPOULE AND VIAL PRODUCT LINES. ...Read More22/04/2024
Compliance Certificate For The Year Ended On 31St March 2024 Please find enclosed herewith Compliance certificate under Reg. 7 (3) of SEBI Re...Read More12/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Reg 74(5) of SEBI (DP) Regulations for q.e. 31-03-2024 is encl...Read More12/04/2024
Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended March 31 2024 Certificate under reg 74(5) of SEBI DP regulations for q.e. 31-03-2024 is enclo...Read More12/04/2024
Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC) The company is not falling under Large Corporate Category as on 31st March 202411/04/2024
Clarification On Delay Submission With Respect To Proceedings Of 40Th Annual General Meeting Held On September 30 2023 We are enclosing herewith clarification on delay in submission of proceedings of...Read More09/04/2024
Closure of Trading Window Closure of Trading window from April 01 202430/03/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More26/02/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More16/02/2024
Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2023 Submission of Unaudited financial results for the quarter and nine months ended ...Read More06/02/2024
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2023 Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Sch...Read More06/02/2024
Board Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2023 Along With Limited Review Report. Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Dir...Read More25/01/2024

Load more